Company: IXHL
Filing Date: 2025-03-24
Form Type: S-3
Source: 0001013762-25-001587
Chunk: 24

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-24
Form: S-3
Chunk 24
---
 registration under the Securities Act, if available, rather than under
this prospectus.

Broker-dealers engaged by
the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of Shares, from the purchaser) in amounts to be
negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary
brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance
with FINRA Rule 2121.

In connection with the sale
of the Shares or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the Shares in the course of hedging the positions they assume. The selling stockholders
may also sell the Shares short and deliver these Shares to close out their short positions, or loan or pledge the Shares to broker-dealers
that in turn may sell the Shares. The selling stockholders may also enter into option or other transactions with broker-dealers or other
financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial
institution of the Shares offered by this prospectus, which Shares such broker-dealer or other financial institution may resell pursuant
to this prospectus (as supplemented or amended to reflect such transaction).

<div align='center'>13</div>

The selling stockholders and
any broker-dealers or agents that are involved in selling the Shares may be deemed to be “underwriters” within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the Shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.
Each selling stockholder has informed us that it does not have any written or oral agreement or understanding, directly or indirectly,
with any person to distribute the Shares.

We are required to pay certain
fees and expenses incurred by us incident to the registration of the Shares. We have agreed to indemnify the selling stockholders against
certain losses, claims, damages and liabilities, including liabilities under the Securities Act.

We have agreed to keep the
registration statement of which this